Page last updated: 2024-09-03

n(6)-carboxymethyllysine and Peripheral Vascular Diseases

n(6)-carboxymethyllysine has been researched along with Peripheral Vascular Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baer, DJ; Ferrucci, L; Gebauer, SK; Novotny, JA; Semba, RD; Silber, HA; Sun, K; Talegawkar, S; Turner, R1

Trials

1 trial(s) available for n(6)-carboxymethyllysine and Peripheral Vascular Diseases

ArticleYear
Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial.
    The Journal of nutrition, 2014, Volume: 144, Issue:7

    Topics: Aged; Biomarkers; Dietary Proteins; Endothelium, Vascular; Female; Follow-Up Studies; Glycation End Products, Advanced; Humans; Hyperemia; Inflammation Mediators; Lysine; Maillard Reaction; Male; Maryland; Middle Aged; Peripheral Vascular Diseases; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Risk; Severity of Illness Index; Solubility; Vascular Resistance; Vasculitis

2014